Get Started

ADXN

NASD Addex Therapeutics Ltd Sponsored ADR
Oct 28, 2026 · 7:46 AM ET EOD Market Closed

$2.99 ↑ +0.00 (+0.00%) Trading Up from the previous close of $2.99, and at the day’s high of $2.99

YTD change
-61.27%
vs 20-day SMA
+0.10%
vs 200-day SMA
-51.30%

Price ranges

Previous day
$2.91 $2.99
open $2.91 close $2.99
+$0.08 (+2.75%)
Today
$2.91 $2.99
$2.99
Past week
$2.89 $3.15
from $2.89 now $2.99
+$0.10 (+3.46%)
Past month
$2.64 $3.25
from $2.81 now $2.99
+$0.18 (+6.41%)
This year
$2.56 $10.43
from $7.72 now $2.99
-$4.73 (-61.27%)

Price & Performance

-3.75 (-55.64%) / 6M

$2.30$3.99$5.67$7.36Apr 28Jul 30Oct 27

Signals & Sentiment

Momentum, market sentiment, and recent alerts

Poor
  • The stock is 99.6% away from all-time highs of $750.40
  • ADXN is down 61% since the beginning of the year
  • ADXN is down 70% over the past 12 months
  • ADXN is up 6% over the past 1 month
  • 0% of all ADXN investors are betting against ADXN

ADXN reads poor: price sits above one of the two key moving averages, the 12-month move is -68.4%.

Financial Strength

Earnings, valuation, and balance sheet

Earnings

Profitable No
EPS $-1.44213
Earnings momentum N/A Quarterly EPS growth
Quarterly change N/A

Valuation

P/E ratio N/A
Enterprise value $2.1M
Beta 1.79

Balance sheet & scale

IncomeN/A
Revenue$107.8K
Cash$951.3K
Debt$96.0
Income / Debt N/A

Company & Peers

Company profile and competitor comparison

Company profile

ExchangeNASD
Sector Manufacturing
Sub Sector Chemical Manufacturing
Market cap $6.8M

Addex Therapeutics Ltd. is a biopharmaceutical company, which engages in the development of drugs for human health. It develops novel, orally available, and small molecule allosteric modulators for neurological disorders. Its pipeline includes Dipraglurant, ADX71149, GABAB PAM, mGlu7 NAM, mGlu2 NAM, mGlu4 PAM, and mGlu3 PAM. The company was founded by Vincent Mutel, Timothy Dyer, and Mark Epping-Jordan in 2002 and is headquartered in Geneva, Switzerland.

Competitor comparison

TickerCompany PriceChange
LLY Eli Lilly and Company $1,281.91 +0.22%
JNJ Johnson & Johnson $268.73 +0.91%
ABBV AbbVie, Inc. $286.39 -0.12%
MRK Merck & Co., Inc. $141.82 +0.86%
RHHBY Roche Holding Ltd Sponsored ADR $60.37 +0.65%

You looked up one stock
Trade Ideas watches them all

Real-time scanning and AI-generated signals across the entire market.

See plans TI Pro Download

Prices and alerts are delayed by at least 20 minutes. Chart history reflects daily closing prices. Information is provided for research purposes only and is not investment advice.